These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8886073)

  • 21. A case of T2 muscle-invasive bladder cancer treated with neoadjuvant chemotherapy.
    Gilbert SM; Lee CT
    Nat Clin Pract Urol; 2006 Dec; 3(12):675-9. PubMed ID: 17149384
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Transitional cell bladder carcinoma in patients younger than 40 years of age].
    Madrid García FJ; Parra Muntaner L; Rivas Escudero JA; Sánchez Sánchez E; Monsalve Rodríguez M; Gómez Cisneros S; García Alonso J
    Arch Esp Urol; 1998 Dec; 51(10):991-4. PubMed ID: 9951121
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Multiple cancer of the urethra after excision of the bladder].
    Nechiporenko NA; Lobkov LN; Gagalinskiĭ VA; Tavrel' VV
    Urol Nefrol (Mosk); 1983; (2):67-8. PubMed ID: 6857875
    [No Abstract]   [Full Text] [Related]  

  • 24. Transitional cell carcinoma of the urinary bladder: a clinicopathological study.
    Matalka I; Bani-Hani K; Shotar A; Bani Hani O; Bani-Hani I
    Singapore Med J; 2008 Oct; 49(10):790-4. PubMed ID: 18946612
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Urethral tumor recurrence following cystectomy and urinary diversion: clinical and pathological characteristics in 768 male patients.
    Stein JP; Clark P; Miranda G; Cai J; Groshen S; Skinner DG
    J Urol; 2005 Apr; 173(4):1163-8. PubMed ID: 15758728
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Transitional cell tumor of the bladder in children: report of a case].
    Sánchez Diaz A; de Nova Sánchez E; Fernandez Puentes JC; García López F; Llorens Martínez F; Orduña Domingo A
    Actas Urol Esp; 1995 Sep; 19(8):642-5. PubMed ID: 8669332
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical analysis of double cancer involving bladder and prostate].
    Yumura Y; Oogo Y; Takase K; Kato Y; Hamano A; Noguchi S; Fukuda M; Satomi Y
    Hinyokika Kiyo; 2006 Apr; 52(4):255-8. PubMed ID: 16686351
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transitional cell carcinoma in the paediatric population: be aware of unusual aetiologies.
    Dowling CR; Reddihough D; Smith P; Webb N; McNeill R; Clouston D
    J Paediatr Child Health; 2007 Nov; 43(11):773-5. PubMed ID: 17924939
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transitional cell carcinoma: a common sense approach.
    Badalament RA
    J Urol; 1995 Jan; 153(1):61-2. PubMed ID: 7966792
    [No Abstract]   [Full Text] [Related]  

  • 30. The management of superficial transitional cell carcinoma of the bladder.
    Sengupta S; Blute ML
    Urology; 2006 Mar; 67(3 Suppl 1):48-54; discussion 54-5. PubMed ID: 16530076
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Urethral recurrence and distant metastases of bladder cancer 9 years after cystectomy and neobladder].
    Kato S; Ito Y; Nishino Y; Ban Y; Deguchi T
    Hinyokika Kiyo; 2005 Mar; 51(3):195-7. PubMed ID: 15852676
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Superficial bladder cancer: the role of molecular markers in the treatment of high-risk superficial disease.
    Malkowicz SB
    Semin Urol Oncol; 1997 Aug; 15(3):169-78. PubMed ID: 9394912
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinico-immunologic characteristics of urooncologic patients].
    Bkhatta AD; Makhlin NV
    Urol Nefrol (Mosk); 1984; (2):47-53. PubMed ID: 6719650
    [No Abstract]   [Full Text] [Related]  

  • 34. Synchronous and multiple transitional cell carcinoma of the bladder and urachal cyst.
    Maletic V; Cerovic S; Lazic M; Stojanovic M; Stevanovic P
    Int J Urol; 2008 Jun; 15(6):554-6. PubMed ID: 18489649
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epigenetic markers as promising prognosticators for bladder cancer.
    Kim YK; Kim WJ
    Int J Urol; 2009 Jan; 16(1):17-22. PubMed ID: 18721202
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Conservative management of mucosal prostatic urethral involvement in patients with superficial transitional cell carcinoma of the bladder.
    Canda AE; Tuzel E; Mungan MU; Yorukoglu K; Kirkali Z
    Eur Urol; 2004 Apr; 45(4):465-9; discussion 469-70. PubMed ID: 15041110
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [A case of synchronous triple primary cancers of prostate, kidney and bladder].
    Harima M; Narita K; Kobayakawa H; Tsujino T; Yamamoto S; Fukushima S; Kishimoto T
    Hinyokika Kiyo; 1998 Sep; 44(9):675-8. PubMed ID: 9805676
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Editorial comment on: EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder.
    Soloway MS
    Eur Urol; 2008 Aug; 54(2):313-4. PubMed ID: 18468783
    [No Abstract]   [Full Text] [Related]  

  • 39. [Bladder tumors].
    Egli U
    Ther Umsch; 1996 Sep; 53(9):697-701. PubMed ID: 8966698
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bladder cancer discovered by ovarian metastasis: cytokeratin expression is useful when making differential diagnosis.
    Ishii Y; Itoh N; Takahashi A; Masumori N; Ikeda T; Tsukamoto T
    Int J Urol; 2005 Jan; 12(1):104-7. PubMed ID: 15661064
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.